News Room

INIS Announces Financial Results For The Third Quarter and The First Nine Months 2022

Wednesday, November 16th, 2022

INIS 2022 3rd Q PR

INIS Announces Financial Results For The Second Quarter And Six Months 2022

Tuesday, August 16th, 2022

INIS 2022 2nd Q 6mo PR

 

INIS Announces Financial Results For The First Quarter 2022

Tuesday, May 17th, 2022

INIS 2022 1st Q PR

INIS Announces 2021 Year End Financial Results

Monday, April 4th, 2022

INIS 2021 10 Earnings Release

INIS Announces Completion Of An Asset Purchase Agreement With Pharmalogic Holdings Corp.

Tuesday, February 22nd, 2022

Pharmalogic APA Press Release

INIS Announces Approval Of Modification To Extend The Maturity Date Of Its Series C Preferred Stock

Thursday, February 17th, 2022

Preferred Series C Press Release

INIS Announces Exclusive Licensing Agreement For Commercialization Of A Radiolabeled Antibody Test For Detecting SARS CoV-2

Tuesday, December 7th, 2021

INIS Announces Exclusive Licensing Agreement For Commercialization Of A Radiolabeled Antibody Test For Detecting SARS CoV-2

INIS Announces It Has Acquired Full Ownership of RadQual LLC

Monday, July 12th, 2021

Radqual acquisition PR 7-12-21 (final)

INIS Announces a Collaboration with LEA for Distribution of Calibration Sources in North America

Tuesday, February 9th, 2021

INIS Announces a Collaboration with Laboratoire D’Etalons D’Activite (LEA) for Distribution of Calibration Sources in North America

International Isotopes Inc. Announces U.S. Food and Drug Administration Approval of Their ANDA for Sodium Iodide I-131

Monday, February 10th, 2020

FDA-Approval-Press-Release